Galectin Therapeutics Statistics
NASDAQ: GALTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.55-0.07 (-1.93%)
Market open · Delayed 15 min · as of Oct 8, 10:13 AM ET
Galectin Therapeutics by the numbers
Galectin Therapeutics has a market capitalization of $358.0 million based on 100.85M shares outstanding. With trailing EPS of $-0.43, Galectin Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.0% below its 50-day average and 10.1% above its 200-day average.
Average daily trading volume is 385.71K shares, or about $1.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GALT valuation vs. peer median
| Metric | GALT | Peer median | Difference |
|---|---|---|---|
| Market cap | $358.02M | $354.44M | +1% |
| Avg. volume | 385.71K | 883.85K | -56% |
Peer median across 8 companies: IRD, TTRX, ARCT, EBS, ENTA, RLMD, AVIR, INDP.
Valuation
- Market cap
- $358.02M
- EPS (TTM)
- $-0.43
- Shares outstanding
- 100.85M
Price and trading
- Previous close
- 3.62
- Open
- 3.62
- Day range
- 3.51 – 3.62
- 52-week range
- 2.03 – 7.13
- 52-week change
- -24.11%
- Beta
- —
- Volume
- 36.41K
- Average volume
- 385.71K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2025
Additional statistics
- Market Cap
- 358.02M
- Forward Pe
- -2.11
- Eps
- -0.43
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.13
- Week52 Low
- 2.03
- Avg Volume
- 385.71K
- Shares Outstanding
- 100.85M
- Ma50
- 3.74
- Ma200
- 3.23
- Earnings Date
- Aug 11, 2025
- Pct From52w High
- -50.21%
- Pct From52w Low
- 74.88%